Dr. Landi Discusses the Importance of Screening in Melanoma

Maria Teresa Landi, MD, PhD
Published: Tuesday, Jan 09, 2018



Maria Teresa Landi, MD, PhD, senior investigator, Integrative Tumor Epidemiology Branch, National Cancer Institute, discusses the importance of screening in melanoma.

There is a balance between the necessity for screening and the overuse of health services, says Landi, but improving prevention is the ultimate goal.

Landi says that if genetic variance is put together into a polygenic risk score, the risk of melanoma can be predicted quite effectively, without the high cost of traditional screening techniques.


Maria Teresa Landi, MD, PhD, senior investigator, Integrative Tumor Epidemiology Branch, National Cancer Institute, discusses the importance of screening in melanoma.

There is a balance between the necessity for screening and the overuse of health services, says Landi, but improving prevention is the ultimate goal.

Landi says that if genetic variance is put together into a polygenic risk score, the risk of melanoma can be predicted quite effectively, without the high cost of traditional screening techniques.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Evolving Roles for Targeted Melanoma Therapies: Assessing Rapid Progress in the Field and Looking Toward Future CombinationsFeb 28, 20191.5
Publication Bottom Border
Border Publication
x